Clinical trial

Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer

NCT02623751

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention KHK2375 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Exemestane Normalized identity: exemestaneView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-11-01

PhasePHASE1

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

KHK2375DRUG

ExemestaneDRUG · verified · RxNorm: exemestane

Sponsors & collaborators

Kyowa Kirin Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02623751 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.